Search research articles
Contact Us
Filters
Showing results (151-160 of 172) with videos related to
Page
of 18
Sort By:
Nature Genetics
|
April 22, 2014
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation
Andrew A Lane, Bjoern Chapuy, Charles Y Lin, et al.
The Lancet. Oncology
|
August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
Alessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease
Peter S Winter, Michelle L Ramseier, Andrew W Navia, et al.
Disaster Medicine and Public Health Preparedness
|
June 18, 2019
Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE)
C Norman Coleman, Judith L Bader, John F Koerner, et al.
Nature Medicine
|
November 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Nature Medicine
|
June 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Cell Reports
|
April 25, 2020
Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma
Deepak Bararia, Johannes A Hildebrand, Sebastian Stolz, et al.
Science Translational Medicine
|
September 20, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
Gongwei Wu, Noriaki Yoshida, Jihe Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2017
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma
Alex F Herrera, Scott J Rodig, Joo Y Song, et al.
Cancer Cell
|
July 16, 2015
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia
Shuo-Chieh Wu, Loretta S Li, Nadja Kopp, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 172) with videos related to
Sort By:
Page
of 18
Nature Genetics
|
April 22, 2014
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation
Andrew A Lane, Bjoern Chapuy, Charles Y Lin, et al.
The Lancet. Oncology
|
August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
Alessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease
Peter S Winter, Michelle L Ramseier, Andrew W Navia, et al.
Disaster Medicine and Public Health Preparedness
|
June 18, 2019
Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE)
C Norman Coleman, Judith L Bader, John F Koerner, et al.
Nature Medicine
|
November 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Nature Medicine
|
June 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Cell Reports
|
April 25, 2020
Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma
Deepak Bararia, Johannes A Hildebrand, Sebastian Stolz, et al.
Science Translational Medicine
|
September 20, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
Gongwei Wu, Noriaki Yoshida, Jihe Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2017
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma
Alex F Herrera, Scott J Rodig, Joo Y Song, et al.
Cancer Cell
|
July 16, 2015
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia
Shuo-Chieh Wu, Loretta S Li, Nadja Kopp, et al.
Page
of 18